Regard, a Los Angeles, CA-based AI-powered clinical insights platform, has raised $61 million in Series B financing.
Investors
The round was led by Oak HC/FT, with participation from Cedars-Sinai Health Ventures, TenOneTen Ventures, Calibrate Ventures, and Techstars.
Oak HC/FT, founded in 2014, is a venture and growth equity firm focusing on fintech and healthcare. With over $5.3 billion in assets, it has invested in 85+ companies, guiding their growth to make lasting industry impacts. Headquartered in Stamford, CT, it also operates an office in San Francisco, CA.
Regard Use of Funds
The company plans to use the funding to accelerate product development of their core clinical insights platform, invest in fundamental research in large language models (LLMs), and expand beyond inpatient facilities.
About Regard
Regard provides an AI clinical insights platform designed to offer healthcare providers clinical insights and decision support. Its technology augments clinical workflows and transforms data into actionable insights, helping health systems maximize the value of their clinical data. This approach improves patient care, saves physicians time, and enhances hospital finances. Regard aims to empower physicians and health systems to leverage AI effectively, enabling them to deliver world-class healthcare.
Funding Details
Company: Regard Technologies, Inc.
Raised: $61.0M
Round: Series B
Funding Month: July 2024
Lead Investors: Oak HC/FT
Additional Investors: Cedars-Sinai Health Ventures, TenOneTen Ventures, Calibrate Ventures, Techstars
Company Website: https://withregard.com/
Software Category: AI Clinical Insights
Source: https://www.prnewswire.com/news-releases/regard-raises-61m-to-close-the-clinical-insights-gap-in-healthcare-with-leading-ai-solution-302194821.html